tbuckley/cabot-search huggingface dataset:
EP08.02-105 KRAS p.G12 Mutated Advanced Non-Small Cell Lung Cancer. Characteristics and Outcomes from a Danish Nationwide Observational Study
Authors: M.T. Frost, D.R. Gotfredsen, T.S. Petersen, K.J. Jensen, E.J. Solem, A.M.S. Sørensen, K. Louie, N. Sroczynski, E. Jakobsen, J.L. Andersen
Journal: Journal of Thoracic Oncology (2022)
journal club
Journal: Kidney International (2022)

Despite several treatment options for lupus nephritis (LN), a significant proportion of patients with LN will progress to end-stage kidney disease (ESKD).As in most kidney diseases, tubulointerstitial damage is related to poor kidney outcomes.Abraham et al. used conventional and multiplexed confocal microscopy and computational machine-learning algorithms to extensively characterize tubulointerstitial inflammation in LN patients who developed or did not develop ESKD.The most remarkable observation made was that tubulointerstitial B cells were increased in patients who did not develop ESKD compared with those who did, although CD4 -T cells were increased in patients who went on to have ESKD compared with those who maintained kidney function.This B-cell-low/ CD4 -T-cell-high interstitial architecture was even more exaggerated in a patient who presented with ESKD.There were no differences in CD4 þ T cells, plasmacytoid dendritic cells, or myeloid dendritic cells (mDCs) between groups, except for a paucity of mDCs in patients presenting with ESKD.Patients with high tubulointerstitial B-cell density tended to have low chronicity scores, whereas patients with high CD4 -T cells tended to have high chronicity scores.The CD4 -T cells were composed of CD8, g-d, and other doublenegative T cells.Taken together, these data suggest that certain T-cell subsets are critical for progress to ESKD in LN patients.The exact mechanism through which T cells drive chronic damage, and which CD4 -T cells are most important, remains to be described.Nonetheless, T-cell-targeted therapeutics may be critical in preserving kidney function in LN.-Brad
MA06.08 Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
Authors: W.E.E. Eberhardt, C. Poettgen, T.C. Gauler, C. Schulte, G. Friedel, H.-G. Kopp, B. Fischer, H. Schmidberger, M. Kimmich, W. Budach, S. Cordes, M. Metzenmacher, R. Hepp de Los Rios, W. Spengler, D. De Ruysscher, C. Belka, S. Welter, D. Luetke Brintrup, M. Guberina, F. Oezkan, K. Darwiche, M. Schuler, K.-H. Jöckel, C. Aigner, G. Stamatis, M. Stuschke
Journal: Journal of Thoracic Oncology (2022)
MA01.08 Impact of [18F]FDG PET/CT-derived Metabolic Parameters on Outcomes in Extensive-stage SCLC
Authors: E. Andrini, G. Lamberti, G. Argalia, E. Fortunati, V. Ambrosini, S. Fanti, D. Campana, A. Ardizzoni
Journal: Journal of Thoracic Oncology (2022)
MA11.07 The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World
Authors: R.S. Avila, K. Krishnan, M. Wynes, C. Connolly, A. McWilliams, J. Logan, C. Henschke, D. Yankelevitz, U. Pastorino, R. Santos, B. Hochhegger, K. Ashizawa, T. Kobayashi, W. Rzyman, M. Jelitto-Gorska, J. Field, J. Mulshine, S. Lam
Journal: Journal of Thoracic Oncology (2022)
MA06.03 Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial
Authors: A. Romero, R. Serna, E. Nadal, J.L. Glez Larriba, A. Martínez-Martí, R. Bernabé, J. Bosch-Barrera, A. Garrido Fernandez, V. Calvo, A. Insa, S. Ponce, N. Reguart, J. De Castro, B. Massutí, R. Palmero, C. Aguado de la Rosa, J. Mosquera, M. Cobo, A. Aguilar, G. López Vivanco, C. Camps, F. Hernando Trancho, R. Lopez Castro, T. Moran, I. Barneto, D. Rodríguez-Abreu, A. Cruz, M. Provencio
Journal: Journal of Thoracic Oncology (2022)
MA12.05 Economic Impact of Delaying Care with Single-Gene Testing Versus Next-Generation Sequencing in Non-small Cell Lung Cancer
Authors: B. Sheffield, K. Eaton, B. Emond, M.-H. Lafeuille, A. Hilts, P. Lefebvre, L. Morrison, E. Ewara, P. Cheema
Journal: Journal of Thoracic Oncology (2022)
EP02.04-007 Phase 2 Trial of Neoadjuvant KRASG12C Directed Therapy with Adagrasib (MRTX849) With or Without Nivolumab in Resectable NSCLC (Neo-KAN)
Authors: S.C. Scott, C. Hu, K. Smith, V. Anagnostou, J. Lee, J. Spicer, P. Illei, E. Prophet, S. Rosner, D. Ettinger, J. Feliciano, C. Hann, V. Lam, B. Levy, J. Murray, J. Brahmer, P. Forde, K. Marrone
Journal: Journal of Thoracic Oncology (2022)
Response to the commentary “Modeling pulse wave velocity trajectories—challenges, opportunities, and pitfalls”
Authors: Rizky I. Sugianto, Nima Memaran, Bernhard M.W. Schmidt, Anke Doyon, Daniela Thurn-Valsassina, Harika Alpay, Ali Anarat, Klaus Arbeiter, Karolis Azukaitis, Aysun K. Bayazit, Ipek K. Bulut, Salim Caliskan, Nur Canpolat, Ali Duzova, Jutta Gellerman, Jerome Harambat, Denise Homeyer, Mieczyslaw Litwin, Francesca Mencarelli, Lukasz Obrycki, Dusan Paripovic, Bruno Ranchin, Rukshana Shroff, Uwe Tegtbur, Jeannine von der Born, Ebru Yilmaz, Uwe Querfeld, Elke Wühl, Franz Schaefer, Anette Melk
Journal: Kidney International (2022)
P1.01-01 Comparison between Protein and Autoantibody Biomarkers for the Early Detection of Lung Cancer
Authors: X. Feng, W.Y.-Y. Wu, J. Onwuka, K. Alcala, K. Smith-Byrne, H. Zahed, F. Guida, J.-M. Yuan, R. Wang, R.L. Milne, J. Bassett, A. Langhammer, K. Hveem, V.L. Stevens, Y. Wang, P. Brennan, B. Melin, M. Johansson, H.A. Robbins, M. Johansson
Journal: Journal of Thoracic Oncology (2022)
MA08.03 Breathe Anew: Designing and Testing the Feasibility of a Novel Intervention for Lung Cancer Survivorship
Authors: Y.S. Patel, M.K. Beauchamp, J. Wald, L. Mbuagbaw, B.L. Key, S.M. Green, W.C. Hanna
Journal: Journal of Thoracic Oncology (2022)
MA11.09 Artificial Intelligence in Lung Cancer Screening: Accuracy and Predictive Value
Authors: R.S.d. Santos, G.B.d.S. Teles, R.C. Chate, G. Szarf, J.P. Franceschini, C.A. de Araújo Neto, M. Ghefter, I. Drokin, M. Guimaraes, B. Hochhegger
Journal: Journal of Thoracic Oncology (2022)
EP01.03-008 Lung Cancer Screening Patients Experiences and Satisfaction: Quantitative and Qualitative Findings From a Survey Study
Authors: J. Perez-Morales, J. Miller, H. Tolbert, R. Pathak, M. Reyes, J.E. Gray, V.N. Simmons, G.P. Quinn, M.B. Schabath
Journal: Journal of Thoracic Oncology (2022)
EP11.02-001 Natural Language Processing to Abstract Preneoplastic and Incidental Pulmonary Lesions from Pathology Reports
Authors: J. Petricca, C. French, R. Ajaj, A. Zelifan, B. Grant, L. Zhan, Y. Zhang, A. Thakral, D. Nicholls, Y.-H.R. Hsu, P. Pal, M. Cabanero, M.S. Tsao, G. Liu
Journal: Journal of Thoracic Oncology (2022)
MA06.05 Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
Authors: G.A. Durm, H. Mamdani, S. Althouse, S. Jabbour, A. Ganti, S. Jalal, J. Chesney, J. Naidoo, B. Hrinczenko, M.J. Fidler, T. Leal, L. Feldman, N. Fujioka, N. Hanna
Journal: Journal of Thoracic Oncology (2022)
OA15.06 Pooled Analysis of Outcomes with Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
Authors: D. Rodriguez-Abreu, Y.-L. Wu, M. Boyer, M.C. Garassino, T.S.K. Mok, Y. Cheng, R. Hui, D.M. Kowalski, A.G. Robinson, J.R. Brahmer, T.A. Leal, G. Lopes, B.C. Cho, N. Nogami, S. Novello, N. Peled, G. de Castro, M.A. Leiby, D. Chirovsky, J. Lin, M.C. Pietanza, M. Reck
Journal: Journal of Thoracic Oncology (2022)
EP16.02-005 Liquid Biopsy Detects Genomic Drivers in Non-small Cell Lung Cancer without EGFR Mutations by Single-plex Testing: WJOG13620L
Authors: D. Hazama, T. Uemura, H. Kenmotsu, K. Meano, K. Wakuda, S. Teraoka, H. Kobe, K. Azuma, T. Yamaguchi, T. Masuda, T. Yokoyama, K. Otsubo, K. Haratani, D. Hayakawa, M. Oki, S. Takemoto, T. Ozaki, T. Okabe, A. Hata, H. Hashimoto, N. Yamamoto, K. Nakagawa
Journal: Journal of Thoracic Oncology (2022)
MA03.05 EGFR mutation Is Not a Risk Factor for Postoperative Recurrence of Lung Adenocarcinoma on Long Follow-up of a Multi-Institutional Cohort
Authors: Y. Matsumura, K. Hayasaka, T. Ohira, S. Shiono, J. Abe, H. Suzuki, Y. Okada
Journal: Journal of Thoracic Oncology (2022)
MA07.09 BBT-176, a 4th generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: PK, Safety and Efficacy from Phase 1 Study
Authors: S.M. Lim, J.S. Ahn, M.-H. Hong, T.M. Kim, H.-A. Jung, H.-A. Jung, S.-H.I. Ou, S. Jeong, Y.-H. Lee, E. Yim, S. Jung, S.-Y. Lee, D.-W. Kim
Journal: Journal of Thoracic Oncology (2022)
P2.13-01 Low EV miR-30c Levels as Biomarker of Increased Tumor Autophagy and Chemoradiotherapy Resistance in Locally Advanced NSCLC
Authors: D. de Miguel Perez, F.G. Ortega, R. Guerrero Tejada, C.B. Peterson, A. Russo, M. Gunasekaran, A.F. Cardona, C.I. Bayarri Lara, A. Garcia-Diaz, F.R. Hirsch, J.A. Lorente, J. Exposito Hernandez, M.J. Serrano, C. Rolfo
Journal: Journal of Thoracic Oncology (2022)
EP02.03-009 Real-world Disease-Free Survival as a Predictor of Overall Survival in Resected Early-Stage Non-Small Cell Lung Cancer
Authors: H. West, X. Hu, D. Chirovsky, Y. Song, S. Zhang, C. Gao, C. Carley, A. Lerner, J. Signorovitch, A. Samkari
Journal: Journal of Thoracic Oncology (2022)
P1.15-12 Patient-reported Outcomes of Cemiplimab versus Chemotherapy in Advanced NSCLC: PD-L1 Level Subgroups in EMPOWER-Lung 1
Authors: S. Kilickap, A. Sezer, M. Gümüş, I. Bondarenko, M. Özgüroğlu, M. Gogishvili, X. He, G. Gullo, P. Rietschel, R.G. Quek
Journal: Journal of Thoracic Oncology (2022)
MA11.03 Updated Cost-Effectiveness Analysis of Lung Cancer Screening for Australia, Capturing Differences in the Impact of NELSON and NLST Outcomes
Authors: S. Behar Harpaz, M. Weber, S. Wade, P. Ngo, P. Vaneckova, P. Sarich, S. Cressman, M. Tammemagi, K. Fong, H. Marshall, A. McWilliams, J. Zalcberg, M. Caruana, K. Canfell
Journal: Journal of Thoracic Oncology (2022)
P2.08-05 Lung Cancer Patients’ Willingness to Attend a Screening Appointment or Lung Health Check: Insights from a Global Patient Experience Survey
Authors: J. Fenemore, W. Boerckel, M. Rigney, A. McNamara, B. Gaspar, J. Mayans, M. Hennink, J. Fox, L. Pretorius, M. Daniels, S. Winstone, R. Thakrar
Journal: Journal of Thoracic Oncology (2022)
EP04.01-016 First Comprehensive Lung Cancer Long-Term Survivorship Analysis - Late Toxicities and Overall Survival
Authors: J.-P. Exner, S. Nadjm, R. Hepp de los Rios, M. Metzenmacher, A.-C. Hoffmann, T.C. Gauler, C. Aigner, G. Stamatis, F. Oezkan, C. Schulte, K. Darwiche, C. Taube, D. Theegarten, T. Plönes, C. Pöttgen, L. Umutlu, H. Hautzel, M. Schuler, M. Stuschke, W.E.E. Eberhardt
Journal: Journal of Thoracic Oncology (2022)
Molecularly defined and functionally distinct cholinergic subnetworks
Authors: Xinyan Li, Hongyan Yu, Bing Zhang, Lanfang Li, Wenting Chen, Quntao Yu, Xian Huang, Xiao Ke, Yunyun Wang, Wei Jing, Huiyun Du, Hao Li, Tongmei Zhang, Liang Liu, Ling-Qiang Zhu, Youming Lu
Journal: Neuron (2022)

Highlights•Molecularly defined and functionally distinct D28K+ and D28K− subnetworks•D28K+ and D28K− subnetworks differ in morphological and physiological properties•D28K+ → VPNs cholinergic subnetwork controls anxiety-like behaviors via Kcnh1•D28K− → DGNs cholinergic subnetwork encodes spatial memory via Cacna1hSummaryCholinergic neurons in the medial septum (MS) constitute a major source of cholinergic input to the forebrain and modulate diverse functions, including sensory processing, memory, and attention. Most studies to date have treated cholinergic neurons as a single population; as such, the organizational principles underling their functional diversity remain unknown. Here, we identified two subsets (D28K+ versus D28K−) of cholinergic neurons that are topographically segregated in mice, Macaca fascicularis, and humans. These cholinergic subpopulations possess unique electrophysiological signatures, express mutually exclusive marker genes (kcnh1 and aifm3 versus cacna1h and gga3), and make differential connections with physiologically distinct neuronal classes in the hippocampus to form two structurally defined and functionally distinct circuits. Gain- and loss-of-function studies on these circuits revealed their differential roles in modulation of anxiety-like behavior and spatial memory. These results provide a molecular and circuitry-based theory for how cholinergic neurons contribute to their diverse behavioral functions.Graphical abstract
EP03.01-009 BrainMets-Cross-Sectional Study To Identify The Presence Of Brain Metastasis At Diagnosis Of Advanced NSCLC EGFRm in Portuguese Patients
Authors: M.E. Teixeira, A. Araújo, B. Parente, F. Barata, M. Soares, V. Hespanhol, G. Fernandes, F. Estevinho, L. Ferreira, M.C. Neves, A.S. Vilariça, J.A. Lopes, T. Almodôvar, M. Felizardo, U. Brito, A. Barroso, L. Barradas, M. Bernardo, A. Meleiro, N. Gil, C. Antunes, F. Bernardo, S. Figueiredo
Journal: Journal of Thoracic Oncology (2022)
EP08.01-049 Unscheduled Hospitalizations in Patients With Thoracic Tumors in the Era of Immunotherapy
Authors: J. Peña-López, I. Ruiz-Gutiérrez, D. Jiménez-Bou, L. Gutiérrez-Sainz, D. Sánchez-Cabrero, L. Ruiz-Giménez, A. Pertejo, D. Viñal, P. Cruz-Castellanos, O. Higuera, J. de Castro
Journal: Journal of Thoracic Oncology (2022)
EP04.01-012 Sex and Age-Related Guideline-Adherence Disparities in Non-Small-Cell Lung Cancer Treatment Patterns: Real-World Data
Authors: N.-M.D. Paakkola, J. Lindqvist, A. Jekunen, E. Sihvo, M. Johansson, H. Andersén
Journal: Journal of Thoracic Oncology (2022)
EP02.03-008 Combined Robotic Assisted Thoracic Surgery (CRATS)
Authors: E.D. Anderson, M. Margolis, R. Krochmal, A.E. Hwalek, P.A. DeBrito, M.K. Sidawy, S. Liu, C. Kim, J.E. Reuss, N. Paudel, E. Strother, M. Hamm
Journal: Journal of Thoracic Oncology (2022)
EP05.02-010 Robotic-Assisted Thoracic Surgery Following Neoadjuvant Chemoimmunotherapy in Patients with Stage III Non-small Cell Lung Cancer
Authors: Y. Gao, J. Jiang, D. Xiao, Y. Zhou, Y. Chen, H. Yang, L. Wang, J. Zeng, B. He, R. He, Z. Liu, M. Li
Journal: Journal of Thoracic Oncology (2022)
EP06.01-012 Impact of COVID-19 on the Stage of Lung Cancer Diagnosis at the Mohamed VI Center for Cancer Treatment in Morocco
Authors: S. Panandtigri, T. Chekrine, M. Bourhafour, Z. Bouchbika, H. Jouhadi, N. Tawfiq, S. Sahraoui, A. Benider
Journal: Journal of Thoracic Oncology (2022)
EP05.01-019 4D CT Ventilation Image-Guided Lung Functional Avoidance Radiotherapy: A Single-Arm Prospective Pilot Clinical Trial
Authors: T. Yamamoto, S. Kabus, M. Bal, P. Keall, A. Moran, C. Wright, S. Benedict, D. Holland, N. Mahaffey, L. Qi, M. Daly
Journal: Journal of Thoracic Oncology (2022)
P2.10-04 Immunologic Subtype of Small Cell Lung Carcinoma Dictates Susceptibility to NK Cell-Mediated Cytotoxicity
Authors: M. Campisi, M. Chen, P. Schol, M. Tarannum, J. Wolff, R. Romee, S. Rodig, D.A. Barbie, N.R. Mahadevan
Journal: Journal of Thoracic Oncology (2022)
EP14.02-001 Could the Oxidative Stress Be Used as a Marker for Neuroendocrine Lung Tumors?
Authors: L.G. Andriolo, A. Spagnoli, V. Cammisotto, D. Alunni Fegatelli, M. Chicone, V. Dell'Anna, G. Di Rienzo, G. Lobreglio, G. Serio, P. Pignatelli
Journal: Journal of Thoracic Oncology (2022)
EP01.05-001 Radiomics to Increase the Effectiveness of Lung Cancer Screening Programs. Radiolung Preliminary Results
Authors: A. Rosell, S. Baeza, S. Garcia-Reina, J.L. Mate, I. Guasch, I. Nogueira, G. Torres, C. Sanchez-Ramos, D. Gil
Journal: Journal of Thoracic Oncology (2022)
EP02.04-009 Real World Survival Outcome Analysis of Adjuvant Therapies in Non-EGFR, Non-ALK Early Stage Resected NSCLC
Authors: T. Hoxha, M. Pienkowski, K. Khan, A. Moore, K. Balaratnam, M.T. Chowdhury, P. Walia, A. Sabouhanian, J. Herman, E. Strom, K. Hueniken, L. Corke, N. Leighl, F.A. Shepherd, P. Bradbury, A. Sacher, S. Cheng, M.C. Brown, V. Mai, M. Garcia, L.J. Zhan, W. Xu, G. Liu
Journal: Journal of Thoracic Oncology (2022)
MA01.07 From Molecular to Histological Characterization of Lung Carcinoids via Computer Vision and Spatial Genomics
Authors: None é. Mathian, A. Sexton Oates, N. Alcala, F. Damiola, G. Centonze, L.N.E.N. network, M. Milione, S. Lantuejoul, L. Chen, L. Fernandez-Cuesta, M. Foll
Journal: Journal of Thoracic Oncology (2022)
P1.15-01 Differential Diagnosis of Pneumonitis in Metastatic NSCLC (Non-Small Cell Lung Cancer) Patients Receiving Immunotherapy With Radiomics
Authors: A. Traverso, F. Tohidinezhad, D. Bontempi, A. Dekker, L. Hendriks, D. De Ruysscher
Journal: Journal of Thoracic Oncology (2022)
EP08.03-005 HALT - Targeted Therapy with or without Dose-Intensified Radiotherapy in Oligo-Progressive Disease in Oncogene Addicted Lung Tumours
Authors: F. McDonald, M. Guckenberger, S. Popat, C. Faivre-Finn, N. Andratschke, A. Riddell, G.G. Hanna, C. Hiley, V. Prakash, A. Nair, P. Diez, P. Patel, L. Kilburn, A. Emmerson, C. Toms, J. Bliss
Journal: Journal of Thoracic Oncology (2022)
OA07.06 Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)
Authors: E. Auclin, J. Benitez-Montanez, T. Gorria, R. Garcia-Campelo, N. Dempsey, D.J. Pinato, R. Reyes, V. Albarran, F. Dall'ollio, D. Soldato, L. Hendriks, F. Aboubakar, M. Tonneau, R. Lopez-Castro, E. Nadal, S. Katsandjian, F. Blanc-Durand, E. Fabre, N. Castro, H. Arasanz, T. Muanza, A. Rochand, B. Besse, B. Routy, L. Mezquita
Journal: Journal of Thoracic Oncology (2022)
EP16.04-014 NTRK in Lung Cancer Patients with History of Hodgkin's Lymphoma
Authors: M. Blanco Clemente, B. Núñez García, V. Calvo de Juan, A. Collazo Lourdy, Y. Garitaonaindía Díaz, M. Martínez Cutillas, C. Traseira Puchol, R. Aguado Noya, G. Visedo Ceballos, S.C. González González, M. Méndez García, J.C. Sánchez González, B. Cantos Sánchez de Ibargüen, C. Parejo, M. Provencio Pulla
Journal: Journal of Thoracic Oncology (2022)
OA11.03 Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Non-Small Cell Lung Cancer: A Marker of Better Prognosis
Authors: P.L. Zhan, M.E. Canavan, T. Ermer, M.D. Pichert, A.X. Li, R.C. Maduka, M.F. Kaminski, D.J. Boffa
Journal: Journal of Thoracic Oncology (2022)
OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors
Authors: G. Falchook, B.T. Li, K.A. Marrone, C.M. Bestvina, C.J. Langer, J.C. Krauss, J.H. Strickler, A. Meloni, T. Dai, T. Varrieur, D.S. Hong
Journal: Journal of Thoracic Oncology (2022)
EP16.03-014 Simultaneous Detection of FGFR Gene Aberrations in Squamous Non-small Cell Lung Cancer Using Targeted DNA- and RNA-based NGS
Authors: J. Moes-Sosnowska, M. Skupinska, U. Lechowicz, P. Skronska, E. Szczepulska-Wojcik, A. Stepniewska, A. Rozy, R. Langfort, P. Rudzinski, T. Orlowski, D. Popiel, M. Wieczorek, J. Chorostowska-Wynimko
Journal: Journal of Thoracic Oncology (2022)
OA09.05 Neoadjuvant IL-15-PDL1 Antibody Promotes T cell Memory and Decreases Metastatic Recurrence in Resectable NSCLC
Authors: J. Villena-Vargas, T. Delgado Cruz, G. Markowitz, A. Singh, S. Martomo, J. Patel, N. Altorki, V. Mittal
Journal: Journal of Thoracic Oncology (2022)
EP01.07-003 Accuracy of Cytological Diagnosis for Malignant Nodule in Participants with Nonsolid Nodules and Part-Solid Nodules With Solid Component≤5 mm
Authors: N. Triphuridet, R. Yip, C.I. Henschke, D.F. Yankelevitz
Journal: Journal of Thoracic Oncology (2022)
EP01.07-004 FDG-PET-CT for Staging Screen Detected Lung Cancer
Authors: R. Meyers, D. Wilson, J. Yee, A.L. McGuire, S. Atkar-Khattra, Q. Ye, J. Mayo, A. Rosell, R. Lopez Lisbona, S. Lam
Journal: Journal of Thoracic Oncology (2022)
OA12.05 Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer
Authors: H. Borghaei, L. Paz-Ares, M. Johnson, S. Champiat, T. Owonikoko, V. Lai, M. Boyer, H.-D. Hummel, R. Govindan, N. Steeghs, F. Blackhall, N. Reguart, A. Dowlati, Y. Zhang, N. Hashemi Sadraei, A. Goldrick, H. Izumi
Journal: Journal of Thoracic Oncology (2022)
MA14.05 A Double-blind Phase III Trial of Denosumab Biosimilar QL1206 vs Denosumab in Bone Metastatic Tumor: Lung Cancer Cohort Data
Authors: Y. Huang, A. Zeng, H. Zhang, Y. Yu, R. Yang, Z. Chen, Y. Zhang, S. Wei, M. Bi, X. Wang, C. Han, Q. Liu, Y. Li, L. Zhang
Journal: Journal of Thoracic Oncology (2022)
EP01.06-007 The Impact of Modified Screening Eligibility Criteria on Race and Sex Disparities in Lung Cancer Screening
Authors: M. Smeltzer, W. Liao, N. Faris, C. Fehnel, J. Lane, S.C. Williams, R. Ramos, T. Qureshi, A. Pacheco, A. Mukhopadhyay, M. Ray, T. Robbins, J. Wright, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2022)
EP01.07-002 Objectives and Design of the ACR Lung Cancer Screening CT Incidental Findings - Quick Reference Guide
Authors: D.S. Dyer, M.R. Gieske, J.P. Kanne, E.A. Kazerooni, M.S. Parker, M. Menchaca, C. Thomson, C. Chiles, C.C. Wu, C.S. White
Journal: Journal of Thoracic Oncology (2022)
P2.06-01 Skip Hilar Lymph Node Metastasis in Non-Small Cell Lung Cancer Has Similar Survival to N0 Disease: Need for a change in the pN sub-classification?
Authors: I. Sarbay, E. Ersen, H.V. Kara, B. Kılıç, Ö.F. Sağlam, G. Güler, K. Kaynak, A. Turna
Journal: Journal of Thoracic Oncology (2022)
P1.15-07 Phase II Study of Pembrolizumab and Itacitinib for First Line Treatment of Metastatic NSCLC Expressing PD-L1
Authors: M.E. Marmarelis, D. Mathew, J.M. Bauml, W.-T. Hwang, J. Zhang, A. Singh, C. D'Avella, C. Davis, D. Ye, L. Sun, C. Ciunci, N. Zhang, C. Aggarwal, R.B. Cohen, A.J. Minn, E.J. Wherry, C.J. Langer
Journal: Journal of Thoracic Oncology (2022)
EP01.02-002 Awareness of Palestinians about Lung Cancer Symptoms: A National Cross-sectional Study
Authors: H. Abukmail, M. Elshami, W. Aqel, M. Alser, I. Al-Slaibi, H. Shurrab, S. Qassem, F.D. Usrof, M. Alruzaygat, R. Nairoukh, A. Mansour, R. Kittaneh, N. Sawafta, Y. Habes, O. Ghanim, W.A. Aabed, O. Omar, M. Daraghmeh, J. Aljbour, R. Elian, A. Zuhour, H. Habes, M. Al-Dadah, N. Abu-El-Noor, B. Bottcher
Journal: Journal of Thoracic Oncology (2022)
MA14.03 Effect of Mirtazapine on Energy Intake in Patients with Anorexia Associated with NSCLC
Authors: O. Arrieta, D. Cardenas-Fernández, O. Rodriguez-Mayoral, L. Zatarain-Barrón, S. Gutierrez-Torres, D. Castañares, E. Reyes, D. López, P. Barragan, D. Heredia, L. Lara-Mejía, A.F. Cardona, D. Flores-Estrada, J.G. Turcott
Journal: Journal of Thoracic Oncology (2022)
EP01.02-001 Citizens’ Perspective on Combination Screening for Lung Cancer, COPD and CVD
Authors: C.M. Behr, H. Koffijberg, M.J. IJzerman, H.-U. Kauczor, M.-P. Revel, M. Silva, O. von Stackelberg, J. van Til, R. Vliegenthart
Journal: Journal of Thoracic Oncology (2022)
P2.12-02 Immune-Cell Distribution Between Tumor Edge and Center Affects Lung Cancer Aggressiveness - Multiplex Immunofluorescence
Authors: S. Matsuoka, T. Eguchi, M. Iwaya, S. Ide, S. Mishima, T. Takeda, K. Miura, K. Hamanaka, K. Shimizu
Journal: Journal of Thoracic Oncology (2022)
EP05.03-008 Surgery after First-Line Alectinib for (Locally) Advanced ALK-rearranged NSCLC: Pathological Response and Peri-Operative Results
Authors: F. Lococo, M. Chiappetta, A. Cancellieri, G. Cardillo, F. Zanelli, G. Mangiameli, L. Toschi, G. Guggino, F. Romano, G. Leuzzi, C. Proto, L. Spaggiari, F. De Marinis, E. Vita, E. Menna, S. Margaritora, E. Bria
Journal: Journal of Thoracic Oncology (2022)
MA13.05 TA0953/HM06, a Novel RET-specific Inhibitor Effective in Extracranial and CNS Disease Models of NSCLC with RETfusions
Authors: I. Odintsov, A.J.W. Lui, L. Delasos, I. Khodos, Q. Chang, M.S. Mattar, M. Vojnic, Y.C. Lu, S. Kunte, A. Bonifacio, C. Giuliano, E. de Stanchina, E. Lovati, M. Ladanyi, R. Somwar
Journal: Journal of Thoracic Oncology (2022)
P1.15-03 Clinical Outcomes Among Patients with Non-small Cell Lung Cancer Who Discontinued Immune Checkpoint Inhibitors Due to Toxicity
Authors: F. Pecci, B. Ricciuti, S. Alden, J. Alessi, V. Vaz, A. Barrichiello, G. Lamberti, M.M. Awad
Journal: Journal of Thoracic Oncology (2022)
EP08.01-072 Clinical Value of Patras Immunotherapy Score (PIOS) Formula in Patients With Advanced NSCLC Treated With Immunotherapy/Chemotherapy
Authors: F.-I. Dimitrakopoulos, P. Christopoulos, M. Elshiaty, L. Daniello, I. Pyrousis, A. Kottorou, T. Makatsoris, H. Kalofonos, A. Koutras
Journal: Journal of Thoracic Oncology (2022)